What is OnKure Therapeutics, Inc.'s net investment in lease?

OnKure Therapeutics, Inc. (OKUR) reported net investment in lease of $288K in Q1 2026.

How has OnKure Therapeutics, Inc.'s net investment in lease changed year-over-year?

OnKure Therapeutics, Inc.'s net investment in lease decreased by 57.4% year-over-year, from $676K to $288K.

What is the long-term trend for OnKure Therapeutics, Inc.'s net investment in lease?

Over 3 years (2022 to 2025), OnKure Therapeutics, Inc.'s net investment in lease has grown at a -33.1% compound annual growth rate (CAGR), from $1.29M to $387K.

OnKure Therapeutics, Inc. OKUR Net Investment in Lease

Net Investment in Lease at other companies

Eikon Therapeutics, Inc. EIKN

——

Inhibrx Biosciences, Inc.INBX

——

Replimune GroupREPL

——

IDEAYA Biosciences, Inc.IDYA

——

Erasca, Inc.ERAS

——

Tango TherapeuticsTNGX

——

Other financials

Income statement

See full

Revenue-—

Operating income-$15.6M+8.1%

Net income-$15.2M+4.8%

EPS (diluted)-$1.11+6.7%

Balance sheet

See full

Cash & equivalents$192.1M+98.7%

Total debt$409.0K-57.2%

Total equity$184.4M+103%

Total assets$198.7M+98.9%

Cash flow

See full

Operating cash flow-$12.9M+7.6%

CapEx$5.0K-72.2%

Free cash flow-$12.9M+7.7%

Valuation

See full

Market cap$184.2M+72.6%

Enterprise value-$7.49M-127%

Returns & leverage

See full

Return on equity-42.7%—

Debt / equity0×0.0×

Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s net investment in lease?: OnKure Therapeutics, Inc. (OKUR) reported net investment in lease of $288K in Q1 2026.
How has OnKure Therapeutics, Inc.'s net investment in lease changed year-over-year?: OnKure Therapeutics, Inc.'s net investment in lease decreased by 57.4% year-over-year, from $676K to $288K.
What is the long-term trend for OnKure Therapeutics, Inc.'s net investment in lease?: Over 3 years (2022 to 2025), OnKure Therapeutics, Inc.'s net investment in lease has grown at a -33.1% compound annual growth rate (CAGR), from $1.29M to $387K.